Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival

World Journal of Surgery

Volumn 37, Issue 6, 2013, Pages 1397-1404

  Partelli, Stefano ^a   Crippa, Stefano ^a   Capelli, Paola ^a   Neri, Anna ^a   Bassi, Claudio ^a   Zamboni, Giuseppe ^a   Barugola, Giuliano ^a   Falconi, Massimo ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; CANCER STAGING; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMAN; LYMPH NODE DISSECTION; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VATER PAPILLA; ARTICLE; BILE DUCT TUMOR;

AGED; AMPULLA OF VATER; CHEMOTHERAPY, ADJUVANT; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATICODUODENECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877772694     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-1995-8     Document Type: Article

References (30)

1. Kim RD, Kundhal PS, McGilvray ID et al (2006) Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202:112-119
2. Howe JR, Klimstra DS, Moccia RD et al (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228:87-94
3. Talamini MA, Moesinger RC, Pitt HA et al (1997) Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 225:590-599 discussion 599-600
4. Westgaard A, Tafjord S, Farstad IN et al (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8:170
5. Todoroki T, Koike N, Morishita Y et al (2003) Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 10:1176-1183
6. Sudo T, Murakami Y, Uemura K et al (2008) Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma. Dig Dis Sci 53:2281-2286
7. Hornick JR, Johnston FM, Simon PO et al (2011) A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: management and outcomes. Surgery 150:169-176
8. Qiao QL, Zhao YG, Ye ML et al (2007) Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg 31:137-143. doi: 10.1007/s00268-006-0213-3 discussion 144-136
9. Winter JM, Cameron JL, Olino K et al (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14:379-387
10. Park JS, Yoon DS, Kim KS et al (2007) Factors influencing recurrence after curative resection for ampulla of Vater carcinoma. J Surg Oncol 95:286-290
11. Brown KM, Tompkins AJ, Yong S et al (2005) Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 140:529-532 discussion 532-523
12. Falconi M, Crippa S, Dominguez I et al (2008) Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol 15:3178-3186
13. Smith DD, Schwarz RR, Schwarz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23:7114-7124
14. Cserni G, Vinh-Hung V, Burzykowski T (2002) Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 81:63-69
15. Wong JH, Johnson DS, Hemmings D et al (2005) Assessing the quality of colorectal cancer staging: documenting the process in improving the staging of node-negative colorectal cancer. Arch Surg 140:881-886 discussion 886-887
16. Swanson RS, Compton CC, Stewart AK et al (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65-71
17. Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165-174
18. Tomlinson JS, Jain S, Bentrem DJ et al (2007) Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 142:723-767 discussion 773-764
19. Hellan M, Sun CL, Artinyan A et al (2008) The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas 37:19-24
20. Ito K, Ito H, Allen PJ et al (2010) Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 251:675-681
21. Ito H, Ito K, D'Angelica M et al (2011) Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 254:320-325
22. American Joint Cancer Commission (2010) AJCC cancer staging handbook. Springer, New York
23. Michalski CW, Kleeff J, Wente MN et al (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265-273
24. Yeo CJ, Cameron JL, Lillemoe KD et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355-366 discussion 366-358
25. Schwarz RE, Smith DD (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13:1189-1200
26. van der Gaag NA, ten Kate FJ, Lagarde SM et al (2008) Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater. Br J Surg 95:735-743
27. Jakub JW, Russell G, Tillman CL et al (2009) Colon cancer and low lymph node count: who is to blame? Arch Surg 144:1115-1120
28. Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281
29. Kim R, Chabot J, Saif MW (2011) Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting", Chicago, June 3-7, 2011. J Pancreas 12:362-363
30. Neoptolemos J (2011) Ampullary cancer ESPAC-3 (v2) trial: a multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of Vater. J Clin Oncol 29; abstract no: LBA4006